QIPT — Quipt Home Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$233.72m
- CA$339.67m
- $221.74m
- 55
- 88
- 48
- 68
C2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.89 | -3.7 | -6.17 | 4.84 | -2.78 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 8.54 | 7.82 | 19.8 | 0.367 | 11.8 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.81 | -4.62 | -8.88 | -1.9 | -8.65 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 8.37 | 14 | 18.7 | 26.3 | 40.5 |
Capital Expenditures | -0.154 | -0.091 | -5.05 | -9.16 | -6.85 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.12 | -7.76 | -12.8 | -33.3 | -76 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | 2.97 | -7.85 | -17.8 | -42.5 | -82.8 |
Financing Cash Flow Items | -1.19 | 5.44 | -1.27 | -4.92 | -6.42 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.02 | 13.7 | 3.91 | -9.85 | 50.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.42 | 19.5 | 5.38 | -26.1 | 8.69 |